Telomir Pharmaceuticals, Inc | WebDisclosure

Basculer en Français

10703	Companies
228992	Keywords
157636	Articles
121597	Press releases

Headlines Articles Press releases Telomir Pharmaceuticals, Inc

Home
Companies
Telomir Pharmaceuticals, Inc

PRESS RELEASE

published on 10/09/2025 at 13:30, 9 months ago

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
Telomir Pharmaceuticals announces new findings showing Telomir-1's impact on aggressive breast cancer cells, targeting iron-dependent regulation and cellular energy pathways

Telomir-1 Telomir Pharmaceuticals Breast Cancer Cells Iron-dependent Regulation Cellular Energy Pathways
BRIEF

published on 10/07/2025 at 13:35, 9 months 2 days ago

Telomir Pharmaceuticals dévoile des résultats précliniques prometteurs dans le traitement du cancer de la prostate

Cancer De La Prostate Telomir-1 Telomir Pharmaceuticals Thérapie Épigénétique Suppresseurs De Tumeurs
BRIEF

published on 10/07/2025 at 13:35, 9 months 2 days ago

Telomir Pharmaceuticals Unveils Promising Preclinical Results in Prostate Cancer Therapy

Prostate Cancer Telomir-1 Telomir Pharmaceuticals Epigenetic Therapy Tumor Suppressors
PRESS RELEASE

published on 10/07/2025 at 13:30, 9 months 2 days ago

Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Resistance
Telomir Pharmaceuticals unveils new preclinical findings showing Telomir-1 reactivates tumor suppressor genes MASPIN and RASSF1A in aggressive prostate cancer models, offering potential for improved chemotherapy response and metastasis control

Prostate Cancer Telomir-1 Telomir Pharmaceuticals Preclinical Findings Tumor Suppressor Genes
BRIEF

published on 09/18/2025 at 14:05, 9 months 21 days ago

Telomir-1 Shows Expanded Targeting of Histone Demethylases

Telomir-1 Telomir Pharmaceuticals Epigenetic Therapy Histone Demethylases Cancer And Aging
BRIEF

published on 09/18/2025 at 14:05, 9 months 21 days ago

Telomir-1 montre un ciblage élargi des déméthylases d'histones

Telomir-1 Telomir Pharmaceuticals Thérapie Épigénétique Histone Demethylases Cancer Et Vieillissement
PRESS RELEASE

published on 09/18/2025 at 14:00, 9 months 21 days ago

Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Targets Additional Histone Demethylase Families, a Unique Profile in Cancer and Aging Not Seen in Other Therapies
Telomir Pharmaceuticals announces Telomir-1's new in vitro results inhibiting KDM5 family, expanding epigenetic therapy possibilities in cancer treatment and aging slowdown

Telomir-1 Telomir Pharmaceuticals Epigenetic Therapy KDM5 Family Inhibition Cancer Aging Treatment
BRIEF

published on 09/09/2025 at 14:05, 10 months ago

Telomir Pharmaceuticals Unveils Promising Preclinical Cancer Data

Cancer Research Telomir-1 Telomir Pharmaceuticals DNA Methylation CDKN2A
BRIEF

published on 09/09/2025 at 14:05, 10 months ago

Telomir Pharmaceuticals dévoile des données précliniques prometteuses sur le cancer

Telomir-1 Telomir Pharmaceuticals Recherche Sur Le Cancer Méthylation De L'ADN CDKN2A
PRESS RELEASE

published on 09/09/2025 at 14:00, 10 months ago

Telomir Pharmaceuticals Announces New Cancer Data in Aggressive Human Prostate Cancer Cells Showing Telomir-1 Resets DNA Methylation to Reactivate CDKN2A, a Master Tumor Suppressor, Outperforming Rapamycin and Chemotherapy
Telomir Pharmaceuticals announces new preclinical findings showing Telomir-1's ability to reverse CDKN2A gene silencing by DNA methylation, potentially restoring cancer cell cycle control and immune surveillance

Cancer Therapy Telomir Pharmaceuticals Preclinical Findings DNA Methylation CDKN2A Gene

Accesswire

Published on 07/09/2026 at 23:05, 42 minutes ago

Caldwell Reports Third Quarter Results and Announces Increase of Quarterly Dividend
Published on 07/09/2026 at 22:30, 1 hour 17 minutes ago

Rio Grande Resources Announces Equity Grants
Published on 07/09/2026 at 18:05, 5 hours 42 minutes ago

Sky Gold Corp Reports on Gold and Multi-Element Results from Drilling at Evening Star, Nevada
Published on 07/09/2026 at 16:00, 7 hours 47 minutes ago

Karbon-X Expands European Compliance Market Capabilities With Spanish EU ETS Registry Account
Published on 07/09/2026 at 14:00, 9 hours 47 minutes ago

Mise à jour de l'entreprise

View all ACCESSWIRE

EQS Group

Published on 07/09/2026 at 19:25, 4 hours 21 minutes ago

LIGHTON CHANGES ITS GOVERNANCE WITH THE APPOINTMENT OF JEAN-PHILIPPE BAERT AS CHIEF EXECUTIVE OFFICER AND MARIE DE LAUZON AS CHAIR OF THE BOARD OF DIRECTORS
Published on 07/09/2026 at 19:25, 4 hours 21 minutes ago

LIGHTON FAIT ÉVOLUER SA GOUVERNANCE AVEC LA NOMINATION DE JEAN-PHILIPPE BAERT EN TANT QUE DIRECTEUR GÉNÉRAL ET DE MARIE DE LAUZON EN TANT QUE PRÉSIDENTE DU CONSEIL D’ADMINISTRATION
Published on 07/09/2026 at 18:50, 4 hours 56 minutes ago

NNS acquires shares in OCI
Published on 07/09/2026 at 18:46, 5 hours ago

OHB publishes results of the subscription offer and announces completion of the capital increase
Published on 07/09/2026 at 18:05, 5 hours 42 minutes ago

lePERMISLIBRE publie son chiffre d’affaires du premier semestre 2026

Les Echos

Published on 07/09/2026 at 18:48, 4 hours 58 minutes ago

Information relative au nombre total des droits de vote et d’actions composant le capital social
Published on 07/09/2026 at 18:47, 4 hours 59 minutes ago

ICADE - CP - Modification du contrat de liquidite au 01 juillet 2026
Published on 07/09/2026 at 18:39, 5 hours 8 minutes ago

ICADE - CP - Bilan semestriel contrat de liquidité S1 2026
Published on 07/09/2026 at 18:00, 5 hours 47 minutes ago

SMTPC - Communiqué sur le Chiffre d'affaires du 2ème trimestre 2026
Published on 07/09/2026 at 18:00, 5 hours 47 minutes ago

Second-quarter 2026 activity: +7% (vs. Q2 2025)

View all LES ECHOS COMFI WIRE